Europe Pulse Oximeter Market Outlook, 2027

Besides this, the outbreak of Coronavirus has increased the adoption of pulse oximeters, used majorly to determine the oxygen saturation rate of the infected patients. These factors are likely to boost the growth of the pulse oximeter market, to a growth rate of over 7% in the coming years. The prevalent lifestyle of the European population which consist of habits which create high risk of cardiovascular and respiratory diseases is among the major factor driving the market growth. These activities include smoking and alcohol consumption. Along with this the increasing incidence of obesity in the region is expected to fuel the market growth in the future.

According to the report titled. “ Europe Pulse Oximeter Market Outlook, 2027” the market in the region was valued at USD 0.66 Billion in the year of 2021. The major reason for this value is the high rate of chronic respiratory impairment in different countries of the region. The European market is expected to witness a paradigm shift such as wide adoption & preference for finger pulse oximeters, which can be considered as a crucial factor in the market development. This increase in adoption rate is due to the desirable attribute of the fingertip oximeter of being highly portable and at the same time being a pocket friendly device for the consumer especially for use in homecare. This is the reason the segment during the forecast period is predicted to have the highest growth rate. The handheld oximeters accounted for more than half of the market revenue in the year 2021. There’s also a lot more room inside the device, compared with a Fingertip Pulse Oximeter which allows the manufacturers to incorporate other functions, such as audible alarms, data storage memory, and rechargeable batteries. Furthermore, the increasing demand for non-invasive methods of healthcare in the region is driving the pulse oximeter market as these devices measure the oxygen saturation levels without intruding the patients personal space. The early diagnoses of respiratory diseases have proven to increase the life expectancy of patients, this need in early diagnoses have lead to development of better products in the region and driven the market in recent times.

Europe is the market in which cardiovascular disease accounts for 45% of all deaths, offering a huge market opportunity. Apart from the swift rise in the geriatric population of the region provide to the demand for pulse oximeters. Along with this the rising government investment in healthcare infrastructure has allowed the Non-Homecare segment which includes Hospitals and other institutes to grow to a market value of around USD 0.5 Billion in 2021. An increase in the awareness for home monitoring is expected to provide lucrative opportunities for market expansion during the forecast period. The home care segment is likely to grow with a CAGR of over 14% in the forecasted period between 2022 and 2027. This is likely due to the rising expenses of hospitals in the region.

Germany, with its high-quality healthcare infrastructure & increasing medical tourism, leads the European market. However, it is also a leading country for disease-causing risk factors, like alcohol consumption, smoking, and obesity. About 20% of the total population has a high prevalence of coronary heart diseases. France is a well-developed economy with several hospitals and a robust regulatory framework. The rising geriatric population, which is suffering from different respiratory diseases, is driving the growth of the pulse oximeter market in the country. Such factors led to an increased need for medical devices especially pulse oximeters. Since the country is known for its high technological expertise, the adoption of pulse oximeters is likely to upsurge in the country, thereby aiding the growth of the studied market in the coming years.

COVID-19 Impact

The market in the region followed the global trend and witnessed a spectacular growth during the pandemic. This is due to the reason that the virus created complications in the respiratory function of the victim. However, this instant upsurge in demand was not completely fulfilled by the manufacturers due to issues in production and supply chain which was the effect of the pandemic as well.

Major Companies Included: CASMED (Edwards Lifesciences Corporation ), Covidien (Medtroni PLCc), Koninklijke Philips NV, Nihon Kohden corporation, ICU Medical Inc., Hillrom Services, Inc., Beckton Dickinson and Company, Contec Medical Systems Co. Ltd., Microtek international private limited, Rossmax International Ltd, Spacelabs Healthcare

Considered in the report

• Geography: Europe
• Base year: 2021
• Historical year: 2016
• Forecasted year: 2027

Countries covered:

• Germany
• United Kingdom
• France
• Spain
• Italy
• Russia

Aspects covered in the report

• Market Size by Value for the period (2016-2027F)
• Market Share by Product type (Fingertip, Handheld & Others)
• Market Share by End User (Hospital and Health Care Facilities & Home Care)
• Market Share by Country
• Market Share by Company

Intended Audience

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the medical device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.